Fabrice Grinda on Bloomberg TV Interview about his Angel Investing and one of his favorite companies:
Spotflux http://spotflux.com
Please see Interview below – Spotflux around 5 minute 30 second mark towards end of interview
Posted in Angel Investing, Bloomberg TV, Fabrice Grinda, Inetellectual Property, internet, Internet Privacy, Internet Security, Investments, SpotFlux, Startups, Technology, Uncategorized on January 10, 2013| Leave a Comment »
Fabrice Grinda on Bloomberg TV Interview about his Angel Investing and one of his favorite companies:
Spotflux http://spotflux.com
Please see Interview below – Spotflux around 5 minute 30 second mark towards end of interview
Posted in Business models, Gerbsman Partners, Investments, tagged Aberdare Ventures, advertising, Blueprint Health, boic, business, Electronic Medical records, Gerbsman Partners, google, Merck Global Health Innovation Fund, NEA, New York Digital Health Accelerator, PricewaterhouseCoopers, research, Rock health, science, Startup Health, Steven Gerbsman, Technology on January 7, 2013| Leave a Comment »
Article from GigaOm.
Between growing interest in fitness tracking devices, mobile health apps and software for adapting to the changing business of health care, digital health had a banner year in 2012.
According to a year-end funding report from health tech accelerator Rock Health, investors poured $1.4 billion into digital health companies last year, which is up 45 percent from their investment total of $968 million in 2011. The report, released Monday by the San Francisco-based non-profit, also indicated a 56 percent increase in the number of deals closed in 2012.
As we’ve reported previously, these are interesting times in health care funding as investors rethink their support of biotech and traditional life sciences firms but back digital health companies that leverage mobile devices, cloud computing, open data, sensors and other emerging technology. Indeed, citing research from PricewaterhouseCoopers, Rock Health’s report said that investment in biotech and medical devices declined 4 percent and 16 percent respectively in 2012.
In total, the report said 134 digital health companies each raised more than $2 million in the last year, with one-third of all deals falling into four categories: healthcare purchasing tools for consumers, personal health tracking, Electronic Medical records and hospital administration.
While 179 firms and organizations invested in digital health companies, most only took part in a single deal, Rock Health said, with just eight investors making three or more investments in 2012. Qualcomm Ventures led the list of the most active investors, followed by Aberdare Ventures, Merck Global Health Innovation Fund and NEA.
The Bay Area and Boston lead the way in the number and value of digital health deals, according to the report. But New York could be coming on strong given the launch of several health startup incubators including Blueprint Health, Startup Health and the New York Digital Health Accelerator in the Big Apple last year.
Read more here.
Posted in Board Of Intellectual Capital, boic, Business models, Community, Economy, Entrepreneurship, internet, Investments, Market research, tagged Android, boic, cnn report, free apache, gadgets, game library, gaming, Gerbsman Partners, gigaom, Kickstarter, ouya, Technology on December 31, 2012| Leave a Comment »
Article from GigaOm.
Despite concerns that Kickstarter wonder Ouya, an Android-based TV gaming console, might not deliver, the project is hitting its deadlines with the release on Friday of 1,200 developer consoles.
Ouya announced that the development kits were being shipped to developers, who can also access the Ouya SDK (ODK) online under a free Apache license.
The release of the hardware and software should give developers time to prepare games for the platform, which is expected to be released to the public around March. That’s still the milestone that everyone will be watching but the signs look good for Ouya to make it there.
An early look at the Ouya UI
The company has been under a lot of scrutiny since it debuted as a Kickstarter project in July. The $99 console, built off the Android platform, raised $8.6 million from more than 63,000 backers. That has raised expectations and also concerns about whether the system is for real and can deliver as promised. We chatted with CEO and founder Julie Uhrman shortly after the launch — she assured us that it wasn’t rocket science putting Ouya together and that she was confident Ouya will hit the market by this spring.
The developer console still has plenty of bugs, Ouya has warned developers, and the triggers and D-pad on the controller are not final. Developers will also get a look at an early version of the console UI.
Following a recent CNN report that most of the biggest Kickstarter projects were shipping late, it’s nice to see that Ouya is keeping to its promise. We still don’t know what the quality and experience is like and what the game library will ultimately be. And as Kickstarter has pointed out, it’s not always important that projects ship on time if the end result suffers. But this thing looks like it’s for real.
Read more here.
Posted in Inetellectual Property, Investments, Technology, Venture Capital, Venture Capital Dispatch, Venture Wire on December 19, 2012| Leave a Comment »
Concerns that Series A rounds will be hard to come by in 2013 are widespread in the venture business, according to a survey being released today.
Forty-five percent of venture capitalists think this will be the most difficult financing to obtain, according to a survey of venture capitalists and startup chief executives by Dow Jones VentureSource and the National Venture Capital Association. That reflects an ongoing debate in the industry about whether seed-stage investors have financed too many consumer Internet startups that will now have trouble tapping the venture capital they need to grow.
Only 13% of the VC respondents said seed/angel financing would be the hardest to get in 2013 while 28% thought it would be Series B financing. The survey, conducted from Nov. 26 to Dec. 7, collected responses from more than 600 venture investors and CEOs of venture-backed startups. Responses were equally divided between the two groups.
A plurality of CEOs-42%–thought it would be more difficult to raise follow-on financing in 2013 versus this year; 36% said it would be the same difficulty and 22% said it would be less difficult.
Nonetheless, 67% of the CEOs said their company will raise additional capital in 2013. And 78% of them thought their company’s valuation would increase. But VCs were less sanguine–38% said valuations in their portfolio would decrease in 2013 compared with 2012.
VCs and CEOs were also of different minds when it came to forecasting the amount of U.S. venture investment next year. Venture capitalists were pessimistic, with 47% saying it would decrease, while 30% of CEOs said it would decrease.
VC attitudes are probably shaped by the frosty fundraising landscape. Of the respondents, 44% said venture capital fundraising would contract in 2013 with less money raised by fewer funds. Another 42% said it would concentrate with more money raised by fewer funds.
“Overall quality of companies is increasing; VC will continue to contract but overall achieve better quality,” said one of the respondents, Derek Small, CEO and president of drug developer Naurex, which this week announced it had raised $38 million in Series B financing.
VCs were upbeat about fund performance, with half of them expecting venture capital returns to improve in 2013. Most VCs predicted that the IPO market would be at least as good as this year, with 40% saying there would be more IPOs than in 2012 and 52% saying the quality would be higher.
Sandy Miller of Institutional Venture Partners said, “2013 should see a sustained good IPO environment rather than the starts and stops of recent years. All the ingredients are in place.”
Such optimism about the IPO market was another point of disagreement between VCs and CEOs, however, as just 29% of CEOs expect the number of IPOs to increase and 37% say the quality will be higher. The two groups agreed, however, that there would be more acquisitions next year of venture-backed companies, with 62% of each group predicting an increase.
Venture investors expect a pickup in business IT and health-care IT investing in 2013, with 61% and 57% seeing increases in those sectors, respectively. Interest in consumer IT has ebbed, with 35% of VCs forecasting an investment increase and 40% foreseeing a decline.
“The B2B tech private company valuation bubble will grow and then pop in October,” predicted Scott Maxwell of OpenView Venture Partners.
VentureSource is a research unit of VentureWire publisher Dow Jones & Co.
Write to Russ Garland at russell.garland@dowjones.com. Follow him on Twitter at @RussGarland